Laser capture microdissection (LCM) is emerging as a premier technology with a point-and-shoot capability designed to rapidly isolate single cells or unique multicellular structures from complex ...

Understanding genomic variation in the context of cancer is paramount to identifying disease drivers and informing personalized treatment for patients. Tumor heterogeneity presents a challenge in ...

(MENAFN- EIN Presswire) EINPresswire/ -- The global Laser Capture Microdissection (LCM) Market is gaining strong momentum as life sciences and clinical research increasingly demand ultra-precise ...

Cutting-edge dual-laser technology delivers power and precision in one device SEATTLE, Nov. 8, 2023 /PRNewswire/ -- Laxco is proud to announce the launch of the Accuva Cellect Laser Capture ...

Correlation of allele-specific HLA loss of heterozygosity in patients with cancer with driver mutations. Baseline heterogeneity of myeloid and stroma cells to predict pCR, baseline lymph node (LN) ...

LMD allows researchers to target a specific cell—or even chromosome—and excise it from the cells that surround it on a slide, or in some cases, on a culture dish. 1 Researchers can use some LMD ...

Therapeutic implications of phosphoproteomics in molecular cancer diagnostics. Utility of [18F]FDG PET/CT in predicting pathological complete response to neoadjuvant therapy in breast cancer: A ...

Leica Microsystems is one of the market leaders in microscopy and scientific imaging. The company develops highly advanced instruments for the analysis of microstructures and nanostructures - ...

SEATTLE, Nov. 8, 2023 /PRNewswire/ -- Laxco is proud to announce the launch of the Accuva Cellect Laser Capture Microdissection (LCM) System. Our innovative system is designed to enable isolation and ...